Suppr超能文献

组蛋白去乙酰化酶调节肾小管间质损伤中的促炎和纤维化改变。

Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.

机构信息

Dept. of Clinical Renal Regeneration, and Div. of Nephrology and Endocrinology, Dept. of Internal Medicine, Univ. of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655 Tokyo, Japan.

出版信息

Am J Physiol Renal Physiol. 2010 Jan;298(1):F133-41. doi: 10.1152/ajprenal.00400.2009. Epub 2009 Nov 11.

Abstract

Histone deacetylase (HDAC) regulates gene expression by modifying chromatin structure. Although changes in the expression and activities of HDAC may affect the course of kidney disease, the role of HDAC in tubulointerstitial injury has not been explored. We therefore investigated the alterations in HDAC expression and determined the effects of HDAC inhibition on the tubulointerstitial injury induced by unilateral ureteral obstruction. The induction of HDAC1 and HDAC2, accompanied by a decrease in histone acetylation was observed in kidneys injured by ureteral obstruction. Immunohistochemical analysis revealed that HDAC1 and HDAC2 were induced in renal tubular cells. Treatment with an HDAC inhibitor, trichostatin A (TSA), attenuated macrophage infiltration and fibrotic changes in tubulointerstitial injury induced by ureteral obstruction. The induction of colony-stimulating factor-1 (CSF-1), a chemokine known to be involved in macrophage infiltration in tubulointerstitial injury, was reduced in injured kidneys from mice treated with TSA. TSA, valproate, and the knockdown of HDAC1 or HDAC2 significantly reduced CSF-1 induced by TNF-alpha in renal tubular cells. These results suggest that tubular HDAC1 and HDAC2, induced in response to injury, may contribute to the induction of CSF-1 and the initiation of macrophage infiltration and profibrotic responses. These findings suggest a potential of HDAC inhibition therapy aimed at reducing inflammation and fibrosis in tubulointerstitial injury.

摘要

组蛋白去乙酰化酶(HDAC)通过修饰染色质结构来调节基因表达。尽管 HDAC 的表达和活性的变化可能会影响肾脏疾病的进程,但 HDAC 在肾小管间质损伤中的作用尚未得到探索。因此,我们研究了 HDAC 表达的变化,并确定了 HDAC 抑制对单侧输尿管梗阻引起的肾小管间质损伤的影响。我们观察到,在输尿管梗阻引起的肾脏损伤中,HDAC1 和 HDAC2 的表达增加,同时组蛋白乙酰化水平降低。免疫组织化学分析显示,HDAC1 和 HDAC2 被诱导在肾小管细胞中。用 HDAC 抑制剂 Trichostatin A(TSA)治疗可减轻输尿管梗阻引起的肾小管间质损伤中的巨噬细胞浸润和纤维化变化。诱导因子-1(CSF-1)是一种已知参与肾小管间质损伤中巨噬细胞浸润的趋化因子,在 TSA 治疗的损伤肾脏中其诱导减少。TSA、丙戊酸以及 HDAC1 或 HDAC2 的敲低显著减少了 TNF-α诱导的肾小管细胞中 CSF-1 的产生。这些结果表明,损伤反应诱导的肾小管 HDAC1 和 HDAC2 可能有助于 CSF-1 的诱导以及巨噬细胞浸润和致纤维化反应的启动。这些发现提示 HDAC 抑制治疗可能具有减轻肾小管间质损伤中的炎症和纤维化的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验